[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367356-105":59,"doc-detail-367356-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-compounds-target-aberrant-calcium-signaling-in-the-treatment-of-relapsed-high-risk-neuroblastoma","Novel Compounds Target Aberrant Calcium Signaling in the Treatment of Relapsed High-Risk Neuroblastoma","","High-risk neuroblastoma (HRNB) is a fatal pediatric solid tumor in which many patients develop refractory disease or therapy-resistant relapse. Aberrant calcium (Ca2+) signaling drives HRNB progression, and although Ca2+ channels are druggable, many also function in normal cells, limiting targeted approaches. This work aims to uncover HRNB-specific Ca2+ signaling pathways as therapeutic targets. Store-operated Ca2+ entry (SOCE) deregulation coordinates endoplasmic reticulum and mitochondrial Ca2+-dependent programs that regulate survival and apoptosis. Two related synthesized compounds disrupt SOCE–ER–mitochondrial signaling, generate HRNB-unique aberrant Ca2+ signals, promote mitochondrial Ca2+ overload and cell death, and suggest a calcium-mediated cell-death pathway for relapsed HRNB.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-compounds-target-aberrant-calcium-signaling-in-the-treatment-of-relapsed-high-risk-neuroblastoma/367356/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-compounds-target-aberrant-calcium-signaling-in-the-treatment-of-relapsed-high-risk-neuroblastoma/367356.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is targeting calcium signaling challenging in high-risk neuroblastoma?","Question",{"text":112,"@type":113},"Many calcium channels implicated in HRNB also carry out essential functions in normal healthy cells. This overlap raises the risk of adverse effects when targeting those channels directly.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does store-operated calcium entry (SOCE) play in HRNB progression?",{"text":117,"@type":113},"SOCE connects Ca2+ release from the endoplasmic reticulum to Ca2+ influx through plasma membrane channels. It supports cancer drug resistance by coordinating transcriptional programs and mitochondrial Ca2+-dependent signaling that control survival and apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the novel compounds affect calcium signaling and cell fate in relapsed high-risk neuroblastoma?",{"text":121,"@type":113},"The study identifies two related compounds that uniquely disrupt the dynamic interplay between SOCE, ER signaling, and mitochondrial pathways. They activate HRNB-specific aberrant Ca2+ signals, induce mitochondrial Ca2+ overload, and trigger subsequent cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367356,1790348412,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nNovel Compounds Target Aberrant Calcium Signaling in the Treatment of Relapsed High-Risk Neuroblastoma  \nDana-Lynn T. Koomoa 1,2,*, Nathan Sunada 1,2, Italo Espinoza-Fuenzalida 2, Dustin Tacdol 2, Madeleine Shackleford 2, Li Feng 2, Dianqing Sun 2 and Ingo Lange 1,2, *  \nAcademic Editor: Dario Marchetti  \nReceived: 11 December 2024  \nRevised: 18 March 2025  \nAccepted: 19 March 2025  \nPublished: 29 March 2025  \nCitation: Koomoa, D.-L.T.; Sunada, N.; Espinoza-Fuenzalida, I.; Tacdol, D.; Shackleford, M.; Feng, L.; Sun, D.; Lange, I. Novel Compounds Target Aberrant Calcium Signaling in the Treatment of Relapsed High-Risk Neuroblastoma. Int. J. Mol. Sci. 2025, 26, 3180. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26073180  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 College of Pharmacy and Health Sciences, Western New England University, Springﬁeld, MA 01119, USA  \n2 The Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, HI 96720, USA; [dianqing@hawaii.edu](dianqing@hawaii.edu) (D.S.)  \n* Correspondence: [dana-lynn.koomoa-lange@wne.edu](dana-lynn.koomoa-lange@wne.edu) (D.-L.T.K.); [ingo.koomoa-lange@wne.edu](ingo.koomoa-lange@wne.edu) (I.L.) Abstract: High-risk neuroblastoma (HRNB) is an extracranial solid pediatric cancer. Despite the plethora of treatments available for HRNB, up to 65% of patients are refractory or exhibit an initial response to treatment that transitions to therapy-resistant relapse, which is invariably fatal. A key feature that promotes HRNB progression is aberrant calcium (Ca2+ ) signaling. Ca2+ signaling is regulated by several druggable channel proteins, offering tremendous therapeutic potential. Unfortunately, many of the Ca2+ channels in HRNB also perform fundamental functions in normal healthy cells, hence targeting them increases the potential for adverse effects. To overcome this challenge, we sought to identify novel Ca2+ signaling pathways that are observed in HRNB but not normal non-cancerous cells with the hypothesis that these novel pathways may serve as potential therapeutic targets. One Ca2+ signaling pathway that is deregulated in HRNB is store-operated Ca2+ entry (SOCE). SOCE relays the release of Ca2+ from the endoplasmic reticulum (ER) and Ca2+ inﬂux via the plasma membrane and promotes cancer drug resistance by regulating transcriptional programming and the induction of mitochondrial Ca2+ (mtCa2+ )-dependent signaling. mtCa2+ signaling is critical for cellular metabolism, reactive oxygen production, cell cycle, and proliferation and has a key role in the regulation of cell death. Therefore, a dynamic interplay between ER, SOCE, and mitochondria tightly regulates cell survival and apoptosis. From a library of synthesized novel molecules, we identiﬁed two structurally related compounds that uniquely disrupt the dynamic interplay between SOCE, ER, and mitochondrial signaling pathways and induce cell death in HRNB. Our results revealed that compounds 248 and 249 activate distinct aberrant Ca2+ signals that are unique torelapsed HRNB and could be exploited to induce mtCa+ overload, a novel calcium inﬂux current, and subsequent cell death. These ﬁndings establish a potential new pathway of calcium-mediated cell death; targeting this pathway could be critical for the treatment of refractory and relapsed HRNB.  \nKeywords: store-operated calcium entry (SOCE); high-risk neuroblastoma; mitochondria; endoplasmic reticulum; calcium release-activated calcium (CRAC) current (ICRAC ); chemoresistance; apoptosis; proliferation; p53; MYCN  \n1. Introduction  \nHigh-risk neuroblastoma (HRNB) is an extracranial solid tumor that has one of the least","cbCaijgCX70NlpvX","https://ap.wps.com/l/cbCaijgCX70NlpvX","pdf",11457433,21,"English","# Abstract\n# Introduction\n## High-risk neuroblastoma outcomes and relapse challenge\n## Role of aberrant calcium signaling\n## SOCE as a key dysregulated pathway","[{\"question\":\"Why is targeting calcium signaling challenging in high-risk neuroblastoma?\",\"answer\":\"Many calcium channels implicated in HRNB also carry out essential functions in normal healthy cells. This overlap raises the risk of adverse effects when targeting those channels directly.\"},{\"question\":\"What role does store-operated calcium entry (SOCE) play in HRNB progression?\",\"answer\":\"SOCE connects Ca2+ release from the endoplasmic reticulum to Ca2+ influx through plasma membrane channels. It supports cancer drug resistance by coordinating transcriptional programs and mitochondrial Ca2+-dependent signaling that control survival and apoptosis.\"},{\"question\":\"How do the novel compounds affect calcium signaling and cell fate in relapsed high-risk neuroblastoma?\",\"answer\":\"The study identifies two related compounds that uniquely disrupt the dynamic interplay between SOCE, ER signaling, and mitochondrial pathways. They activate HRNB-specific aberrant Ca2+ signals, induce mitochondrial Ca2+ overload, and trigger subsequent cell death.\"}]","Novel Compounds Target Aberrant Calcium Signaling in the Treatment of Relapsed High-Risk Neuroblastoma | PDF",1790170441,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fd2365ed24de48d20fa8ba7ddfd6d4e.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d486360173e972574d9b8dd93b269573.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b27ffcfcc2b489503519cd93319083fa.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/988e75d061712522e666836f879bd373.webp",980,1385]